LEADER 03476nam  22006615  450 
001 9910300240803321
005 20200706104329.0
010   $a3-319-16018-4
024 7 $a10.1007/978-3-319-16018-4
035   $a(CKB)3710000000394739
035   $a(EBL)2094474
035   $a(SSID)ssj0001501367
035   $a(PQKBManifestationID)11771918
035   $a(PQKBTitleCode)TC0001501367
035   $a(PQKBWorkID)11524214
035   $a(PQKB)10109592
035   $a(DE-He213)978-3-319-16018-4
035   $a(MiAaPQ)EBC2094474
035   $a(PPN)185485677
035   $a(EXLCZ)993710000000394739
100   $a20150411d2015      u|         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aBiomarkers of Cardiometabolic Risk, Inflammation and Disease /$fedited by Filipe Palavra, Flįvio Reis, Daniela Marado, Armando Sena
205   $a1st ed. 2015.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2015.
215   $a1 online resource (172 p.)
300   $aDescription based upon print version of record.
311   $a3-319-16017-6 
320   $aIncludes bibliographical references at the end of each chapters and index.
327   $aInflammation biomarkers and cardiometabolic risk -- Cardiovascular disease -- Diabetes mellitus and metabolic syndrome -- Ischemic stroke -- Chronic kidney disease -- Immune-mediated inflammatory rheumatic diseases -- Cardiometabolic risk, inflammation and neurodegenerative disorders.
330   $aThis book discusses recent advances in the area of cardiometabolic risk biomarkers of chronic inflammatory and cardiovascular disorders. Tackling the topic in a systematic manner, the book starts with an introduction to cardiometabolic risk and its clinical relevance, comparing emergent and classical biomarkers. It then goes on to discuss cardiometabolic risk biomarkers in a range of diseases, including diabetes, ischemic stroke and neurodegenerative disorders.   Biomarkers of Cardiometabolic Risk, Inflammation and Disease is aimed at doctors specializing in internal medicine, neurology, cardiology, rheumatology, nephrology or endocrinology and will also be of interest to GPs, trainee doctors, and clinical and basic researchers working on cardiovascular and autoimmune disorders.
606   $aInternal medicine
606   $aMedicine
606   $aNeurology 
606   $aInternal Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/H33002
606   $aBiomedicine, general$3https://scigraph.springernature.com/ontologies/product-market-codes/B0000X
606   $aNeurology$3https://scigraph.springernature.com/ontologies/product-market-codes/H36001
615  0$aInternal medicine.
615  0$aMedicine.
615  0$aNeurology .
615 14$aInternal Medicine.
615 24$aBiomedicine, general.
615 24$aNeurology.
676   $a610
676   $a616
676   $a616.8
702   $aPalavra$b Filipe$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aReis$b Flįvio$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aMarado$b Daniela$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aSena$b Armando$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910300240803321
996   $aBiomarkers of Cardiometabolic Risk, Inflammation and Disease$91760469
997   $aUNINA